| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 23585-22-0 | Benzo[1,2-c:4,5-c']dipyrazole-4,8(1H,7H)-dione,3a,4a,7a,8a-tetrahydro-3a,4a,7a,8a-tetramethyl-; NSC 244470 |  | C12H16N4O2 | 詳情 | 供應商 | |
| 4257-92-5 | Cyclo(histidyl-prolyl) |  | C12H16N4O2 | 詳情 | 供應商 | |
| 24503-77-3 | Ethanediamide,N1-[3-(1-aziridinyl)propyl]-N2-3-pyridinyl-; Oxamide,N-[3-(1-aziridinyl)propyl]-N'-3-pyridyl- (8CI); NSC 224107 |  | C12H16N4O2 | 詳情 | 供應商 | |
| 24482-29-9 | Ethanediamide, N1-[3-(1-aziridinyl)propyl]-N2-2-pyridinyl-; Oxamide, N-[3-(1-aziridinyl)propyl]-N'-2-pyridyl-(8CI); NSC 224109 |  | C12H16N4O2 | 詳情 | 供應商 | |
| 112735-03-2 | Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione,1,3-dimethyl-5-[(1-methylethyl)amino]- |  | C12H16N4O2 | 詳情 | 供應商 | |
| 112500-72-8 | Pyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione,1,3-dimethyl-5-[(1-methylethyl)amino]- |  | C12H16N4O2 | 詳情 | 供應商 | |
| 164468-01-3 | 1,3-Butanedione,1-[4-(2-pyrimidinyl)-1-piperazinyl]-; Piperazine,1-(1,3-dioxobutyl)-4-(2-pyrimidinyl)- (9CI) |  | C12H16N4O2 | 詳情 | 供應商 | |
| 103248-16-4 | 1H-Benzimidazole-1-methanamine,N,N-diethyl-6-nitro- |  | C12H16N4O2 | 詳情 | 供應商 | |
| 80944-67-8 | 1,4-Phthalazinedione,6-[(2-aminoethyl)ethylamino]-2,3-dihydro-; 6-(N-(4-aminoethyl)-N-ethyl)amino-2,3-dihydro-1,4-phthalazine-1,4-dione |  | C12H16N4O2 | 詳情 | 供應商 | |
| 35873-49-5 | 1H-Purine-2,6-dione,8-cyclopentyl-3,9-dihydro-1,3-dimethyl-; 1H-Purine-2,6-dione,8-cyclopentyl-3,7-dihydro-1,3-dimethyl- (9CI); 1,3-Dimethyl-8-cyclopentylxanthine; 8-Cyclopentyl-1,3-dimethylxanthine; 8-Cyclopentyltheophylline; CPT; NSC 101806; PD 116600 |  | C12H16N4O2 | 詳情 | 供應商 | |
| 17243-68-4 | 1-Phthalazinamine,4-[2-(dimethylamino)ethoxy]-N-hydroxy-; 1(2H)-Phthalazinone,4-[2-(dimethylamino)ethoxy]-, oxime (8CI,9CI); Taloximine |  | C12H16N4O2 | 詳情 | 供應商 | |
| 54924-46-8 | T5MVNTJ C2MVMR [WLN] |  | C12H16N4O2 | 詳情 | 供應商 | |